Going Boldly Forth

Gregory Hannon believes in taking risks—an approach that’s enabled him to make exciting new discoveries in the world of small RNAs.

Written byKaren Hopkin
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

GREGORY J. HANNON
Professor and HHMI Investigator
Cold Spring Harbor Laboratory
© MAX S. GERBER
As a student at Case Western University in the 1980s, Greg Hannon got his first taste of honest-to-goodness bucket biochemistry. “I was purifying something called Bence Jones protein from huge buckets of urine,” he says. “It involved running these giant, six-foot-tall sizing columns—a job that was not particularly pleasant, so perfect for an undergraduate.”

But Hannon was even more productive outside the cold room. “I had learned a little computer programming in high school—back when people were still writing code in Basic,” he says. “So, using the coordinates from the protein data bank, I wrote what was probably the first 3-D protein structure visualization program on a PC.” The effort allowed his advisor, Joyce Jentoft, to take a closer look at the Bence Jones protein—and a lot of other things. “For awhile she partly funded her lab distributing that program at 25 bucks a pop.”

The project also earned Hannon his first publication—in Computer Applications in the Biosciences—and ignited his passion for technology development. “Whether it’s writing thousands of lines of code or manipulating oligos on a microarray, I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies